Goal Setting and Mobile-based Self-management Tool to Improve Diet Quality of People With High Blood Pressure

NCT06988501 · tracked via the Priya Life Science China tracker

Sponsor

China National Center for Cardiovascular Diseases

Phase

Not applicable

Started

2024-07-02

Last updated

2025-05-25

Condition(s) studied

Blood Pressure, High

Investigational drug(s) / intervention(s)

Goal setting with mobile-based self-management toolNutrition education

Goal setting with mobile-based self-management tool: In addition to the nutrition education provided to both groups, the participants of the intervention group will work with the dietitian to make behavior-change goals based on SMART goal setting strategy. They will also have access to diet tracking function and weekly report on smart phone application. The dietitian will also meet with the participants virtually to track their progress and provide suggestions.

Nutrition education: The control group will receive nutrition education about blood pressure management by the dietitian

Study summary

SMART goal setting is a patient-led method that can help improve execution and facilitate behavioral changes. Functions such as diet tracking, interaction, and feedback in smartphone application may help enhance patient compliance. This study aims to explore the nutrition intervention measures of SMART goal setting combined with smartphone applications for daily self-management on the effect of improving diet quality of people with high blood pressure.

Eligibility

Sex

ALL

Min age

20 Years

Max age

70 Years

Healthy volunteers

Inclusion Criteria: * Age 20-70; * Hypertension diagnosis, or high blood pressure (SBP between 120-139 mmHg and/or DBP between 80-89 mmHg); * Eating an unhealthy diet (estimated DASH score \< 6) ; * Owning a smartphone and able to operate it proficiently; * Sign the informed consent. Exclusion Criteria: * Severe cardiovascular and respiratory diseases, such as acute myocardial infarction, tachyarrhythmia, pulmonary edema, and severe aortic stenosis; * Acute phase of cardiovascular and cerebrovascular diseases; * Uncontrolled blood pressure; * Diagnosed mental diseases or epilepsy; * Cardiac pacemaker implantation; * Allergic constitutions; * Pregnant women or planning to become pregnant; * Individuals who have participated in other clinical studies within the past 3 months; * Refuse to sign the informed consent.

Primary outcome measure(s)

Diet quality — From enrollment to the end of treatment at 12 weeks
Diet quality is measured by the DASH Score that includes eight dietary components to reflect the adherence to the DASH dietary pattern.

Trial sites (1)

Facility	City	Region	Status
Fuwai Hospital, National Center for Cardiovascular Diseases	Beijing	Beijing Municipality	Recruiting

More China National Center for Cardiovascular Diseases trials in China

No-Touch Versus Conventional Saphenous Vein Harvesting Technique Active, not recruiting

A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation Starting soon

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI Recruiting

CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study Recruiting

An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06988501 on ClinicalTrials.gov ↗ ← All trials in China